(Q35174436)

6 August 2017

1 reference

title

Hepatocellular carcinoma: surgical indications and results (English)

1 reference

6 August 2017

main subject

hepatocellular carcinoma

1 reference

inferred from title

author name string

Guillermo Marín-Hargreaves

series ordinal

1

1 reference

6 August 2017

Daniel Azoulay

series ordinal

2

1 reference

6 August 2017

Henri Bismuth

series ordinal

3

1 reference

6 August 2017

publication date

1 July 2003

1 reference

Critical Reviews in Oncology Hematology

6 August 2017

published in

1 reference

6 August 2017

volume

47

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

13-27

1 reference

Epidemiology of primary liver cancer

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Incidence of primary liver cancer and aetiological aspects: a study of a defined population from a low-endemicity area

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Rising incidence of hepatocellular carcinoma in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

The natural history of hepatocellular carcinoma. A study of 100 untreated cases

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Results after nonsurgical local treatment of primary liver malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Should hepatomas be treated with hepatic resection or transplantation?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Liver transplantation for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated treatment strategy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Hepatic resection for hepatocellular carcinoma. An audit of 343 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

The National Cancer Data Base Report on treatment patterns for hepatocellular carcinomas: improved survival of surgically resected patients, 1985-1996.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Retrospective analysis of type of hepatic resection for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Dynamics of normal and injured human liver regeneration after hepatectomy as assessed on the basis of computed tomography and liver function

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Detection of malignant tumors in end-stage cirrhotic livers: efficacy of sonography as a screening technique

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Detection of hepatocellular carcinoma: value of adding delayed phase imaging to dual-phase helical CT.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Small hepatocellular carcinomas and associated nodular lesions of the liver: pathology, pathogenesis, and imaging findings

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Value of lipiodol computed tomography and digital subtraction angiography in the era of helical biphasic computed tomography as preoperative assessment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Small hypervascular hepatocellular carcinoma versus hypervascular pseudolesions: differential diagnosis on MRI

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Prospective comparative study of spiral computer tomography and magnetic resonance imaging for detection of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Surgical anatomy and anatomical surgery of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

The use of operative ultrasound in surgery of primary liver tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Segmental hepatic resection utilizing the ultrasonic dissector

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

V. Notes on the Arrest of Hepatic Hemorrhage Due to Trauma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Segmental liver resection using ultrasound-guided selective portal venous occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Major and minor segmentectomies "réglées" in liver surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Surgical treatment of hepatocellular carcinomas in noncirrhotic liver: experience with 68 liver resections.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Options for elective treatment of portal hypertension in cirrhotic patients in the transplantation era.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

The indocyanine green test enables prediction of postoperative complications after hepatic resection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Criteria for safe hepatic resection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Risk factors linked to postoperative morbidity in patients with hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Is surgery for large hepatocellular carcinoma justified?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

A logical approach to hepatocellular carcinoma presenting with jaundice

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Laparoscopy and laparoscopic ultrasonography avoid exploratory laparotomy in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Lipiodol computed tomography for small hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Extension of surgical indications for hepatocellular carcinoma by portal vein embolization

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Effect of preoperative portal vein embolization on major hepatectomy for advanced-stage hepatocellular carcinomas in injured livers: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Evaluation of hepatic resection for hepatocellular carcinoma in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Liver resection for hepatocellular carcinoma in octogenarians

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Prognostic factors after hepatectomy for hepatocellular carcinomas. A univariate and multivariate analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Resection of hepatocellular carcinomas. Results in 72 European patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Experience with 225 hepatic resections for hepatocellular carcinoma over a 4-year period

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Recurrence of hepatocellular carcinoma in the liver remnant after hepatic resection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Results of major hepatectomy for large primary liver cancer in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Postoperative recurrence of hepatocellular carcinoma. Two hundred five consecutive patients who underwent hepatic resection in 15 years.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Results of hepatic resection for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Surgical resection for small hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. Result of multivariate analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Hepatocellular Carcinoma and Cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Results of 280 liver resections for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Resection of hepatocellular carcinoma in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Prognostic factors affecting long term outcome after liver resection for hepatocellular carcinoma: results in a series of 100 Italian patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Changes and results of surgical strategies for hepatocellular carcinoma: results of a 15-year study on 452 consecutive patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Resection of hepatocellular carcinoma in cirrhotic patients: longterm results of a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Prognostic factors after hepatic resection for hepatocellular carcinoma associated with Child-Turcotte class B and C cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

An analysis of 412 cases of hepatocellular carcinoma at a Western center

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Impact of hospital volume on operative mortality for major cancer surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

The relationship between hospital volume and outcomes of hepatic resection for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis-C-virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Surgical resection for recurrent hepatocellular carcinoma: prognosis and analysis of risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Repeated liver resection for recurrent liver cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Predictive factors for postoperative recurrence of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Clinical management of recurrent hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Rationale of surgical management for recurrent hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Clonal Origin of Recurrent Hepatocellular Carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Determination of the clonal origin of multiple human hepatocellular carcinomas by cloning and polymerase chain reaction of the integrated hepatitis B virus DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Recurrence of hepatocellular carcinoma after surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Postoperative hepatitis status as a significant risk factor for recurrence in cirrhotic patients with small hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Surgical margin and recurrence after resection of hepatocellular carcinoma in patients with cirrhosis. Further evaluation of limited hepatic resection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

The association between transfusion and cancer-free survival after curative resection for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Anterior approach for difficult major right hepatectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

One hundred consecutive hepatic resections. Blood loss, transfusion, and operative technique

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

The Potential Role of Postoperative Hepatic Artery Chemotherapy in Patients with High-risk Hepatomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Postoperative prophylactic lipiodolization reduces the intrahepatic recurrence of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Role of surgical treatment for recurrent hepatocellular carcinoma after hepatic resection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Repeat hepatectomy for recurrent hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Place of cryosurgery in the treatment of malignant liver tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Cryotherapy for primary liver cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Role of liver transplantation in cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Liver transplantation for malignant disease. Results in 93 consecutive patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Hepatic resection versus transplantation for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900213-5

7 January 2021

10.1016/S1040-8428(02)00213-5

Identifiers

DOI

1 reference

6 August 2017

1 reference